In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis

体外试验表明,泰利霉素 (HMR 3647) 对立克次体属的病原体包括:立克次体(Rickettsia rickettsii)、科诺立克次体(Rickettsia conorii)、非洲立克次体(Rickettsia africae)、伤寒立克次体(Rickettsia typhi)、普氏立克次体(Rickettsia prowazekii)、伯氏考克斯体(Coxiella burnetii)、汉氏巴尔通体(Bartonella henselae)、五日热巴尔通体(Bartonella quintana)、杆状巴尔通体(Bartonella bacilliformis)和查菲埃立克体(Ehrlichia chaffeensis)。

阅读:2

Abstract

In vitro activities of telithromycin compared to those of erythromycin against Rickettsia spp., Bartonella spp., Coxiella burnetii, and Ehrlichia chaffeensis were determined. Telithromycin was more active than erythromycin against Rickettsia, Bartonella, and Coxiella burnetii, with MICs of 0.5 microg/ml, 0.003 to 0.015 microg/ml, and 1 microg/ml, respectively, but was inactive against Ehrlichia chaffeensis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。